This is an excerpt of a 1,970-word article in the June 22, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: After introducing some 200 serological assays onto the market in March and April with little or no review, as of this writing […]
FDA Says 8 of 11 Tests Fail in Serology Test Review
Only three of the COVID-19 serology tests with EUAs met the FDA’s published requirements when evaluated
- By Robert Michel
- > From the Volume XXVII No. 9 - June 22, 2020 Issue
- Tags: clinical lab, clinical laboratories, Clinical Laboratory, clinical laboratory industry, COVID-19, COVID-19 serological tests, COVID-19 serology tests, COVID-19 test, covid-19 testing, COVID-19 tests, FDA Emergency Use Authorization (EUA), Food and Drug Administration (FDA), lab test, lab testing, lab tests, laboratory test, laboratory testing, laboratory tests, National Cancer Institute, Pathology group, pathology groups, pathology lab, the clinical laboratory
